143 related articles for article (PubMed ID: 38436725)
21. Immunocompromised Patients with Therapy-Refractory Chronic Skin Diseases Show Reactivation of Latent Epstein‒Barr Virus and Cytomegalovirus Infection.
Speth P; Jargosch M; Seiringer P; Schwamborn K; Bauer T; Scheerer C; Protzer U; Schmidt-Weber C; Biedermann T; Eyerich S; Garzorz-Stark N
J Invest Dermatol; 2022 Mar; 142(3 Pt A):549-558.e6. PubMed ID: 34480891
[TBL] [Abstract][Full Text] [Related]
22. Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation.
Jaskula E; Dlubek D; Sedzimirska M; Duda D; Tarnowska A; Lange A
Transplant Proc; 2010 Oct; 42(8):3273-6. PubMed ID: 20970670
[TBL] [Abstract][Full Text] [Related]
23. Viral reactivation in the lungs of patients with severe pneumonia is associated with increased mortality, a multicenter, retrospective study.
Huang L; Zhang X; Pang L; Sheng P; Wang Y; Yang F; Yu H; Huang X; Zhu Y; Zhang N; Cai H; Tang L; Fang X
J Med Virol; 2023 Jan; 95(1):e28337. PubMed ID: 36418241
[TBL] [Abstract][Full Text] [Related]
24. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.
Sanosyan A; Daien C; Nutz A; Bollore K; Bedin AS; Morel J; Zimmermann V; Nocturne G; Peries M; Guigue N; Gottenberg JE; Van de Perre P; Mariette X; Tuaillon E
Front Immunol; 2019; 10():1153. PubMed ID: 31191532
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus reactivation in sepsis due to community-acquired pneumonia is associated with increased morbidity and an immunosuppressed host transcriptomic endotype.
Goh C; Burnham KL; Ansari MA; de Cesare M; Golubchik T; Hutton P; Overend LE; Davenport EE; Hinds CJ; Bowden R; Knight JC
Sci Rep; 2020 Jun; 10(1):9838. PubMed ID: 32555213
[TBL] [Abstract][Full Text] [Related]
26. Frequent co-reactivation of Epstein-Barr virus in patients with cytomegalovirus viremia under immunosuppressive therapy and/or chemotherapy.
Hatayama Y; Hashimoto Y; Motokura T
J Int Med Res; 2020 Nov; 48(11):300060520972880. PubMed ID: 33249964
[TBL] [Abstract][Full Text] [Related]
27. Features of Epstein-Barr virus reactivation after allogeneic hematopoietic cell transplantation in Korean children living in an area of high seroprevalence against Epstein-Barr virus.
Han SB; Bae EY; Lee JW; Jang PS; Lee DG; Chung NG; Jeong DC; Cho B; Lee SJ; Kang JH; Kim HK
Int J Hematol; 2014 Aug; 100(2):188-99. PubMed ID: 24981711
[TBL] [Abstract][Full Text] [Related]
28. [Guillain-Barré syndrome associated with Epstein-Barr virus and cytomegalovirus reactivation during treatment for chronic graft-versus-host disease after allogeneic bone marrow transplantation].
Hosoi H; Tane M; Kosako H; Sakaki A; Wada Y; Nakayama Y; Hiroi T; Hori Y; Yamashita Y; Mushino T; Murata S; Nishikawa A; Miyamoto K; Ito H; Sonoki T
Rinsho Ketsueki; 2023; 64(10):1280-1285. PubMed ID: 37914241
[TBL] [Abstract][Full Text] [Related]
29. Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation.
van Esser JW; Niesters HG; van der Holt B; Meijer E; Osterhaus AD; Gratama JW; Verdonck LF; Löwenberg B; Cornelissen JJ
Blood; 2002 Jun; 99(12):4364-9. PubMed ID: 12036863
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of Epstein-Barr virus reactivation in pregnancy.
Haeri S; Baker AM; Boggess KA
Am J Perinatol; 2010 Oct; 27(9):715-9. PubMed ID: 20387188
[TBL] [Abstract][Full Text] [Related]
31. Alterations in NKG2A and NKG2C Subsets of Natural Killer Cells Following Epstein-Barr Virus Reactivation in CTLA4Ig-based Haploidentical Transplantation Is Associated With Increased Chronic Graft-Versus-Host Disease.
Jaiswal SR; Bhakuni P; Bhagwati G; Aiyar HM; Chakrabarti A; Chakrabarti S
Transplantation; 2020 Jan; 104(1):e23-e30. PubMed ID: 31478993
[TBL] [Abstract][Full Text] [Related]
32. Positive Epstein-Barr virus detection and mortality in respiratory failure patients admitted to the intensive care unit.
He H; Wang Y; Wu M; Sun B
Clin Respir J; 2017 Nov; 11(6):895-900. PubMed ID: 26663042
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of primary Epstein-Barr virus infection disease spectrum and its reactivation in children, in Suzhou, China.
Shi T; Huang L; Chen Z; Tian J
J Med Virol; 2021 Aug; 93(8):5048-5057. PubMed ID: 33719067
[TBL] [Abstract][Full Text] [Related]
34. Aged-associated cytomegalovirus and Epstein-Barr virus reactivation and cytomegalovirus relationship with the frailty syndrome in older women.
Thomasini RL; Pereira DS; Pereira FSM; Mateo EC; Mota TN; Guimarães GG; Pereira LSM; Lima CX; Teixeira MM; Teixeira AL
PLoS One; 2017; 12(7):e0180841. PubMed ID: 28700679
[TBL] [Abstract][Full Text] [Related]
35. Association between hypertension and Epstein-Barr virus reactivation among the population in a high-risk area for nasopharyngeal carcinoma.
Lin K; Zeng Z; Li X; Chen W; Lin D; Xie S; Wu Z; Li M; Cao S; Du J
Virus Res; 2023 Jul; 331():199117. PubMed ID: 37105437
[TBL] [Abstract][Full Text] [Related]
36. Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers.
Maurmann S; Fricke L; Wagner HJ; Schlenke P; Hennig H; Steinhoff J; Jabs WJ
J Clin Microbiol; 2003 Dec; 41(12):5419-28. PubMed ID: 14662920
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 associated EBV reactivation and effects of ganciclovir treatment.
Meng M; Zhang S; Dong X; Sun W; Deng Y; Li W; Li R; Annane D; Wu Z; Chen D
Immun Inflamm Dis; 2022 Apr; 10(4):e597. PubMed ID: 35349757
[TBL] [Abstract][Full Text] [Related]
38. Inverse correlation of Vδ2
Liu J; Bian Z; Wang X; Xu LP; Fu Q; Wang C; Chang YJ; Wang Y; Zhang XH; Jiang Z; Huang XJ
Br J Haematol; 2018 Jan; 180(2):276-285. PubMed ID: 29270985
[TBL] [Abstract][Full Text] [Related]
39. [Clinical outcomes of allogeneic hematopoietic stem cell transplantation patients with co-activation of cytomegalovirus and Epstein-Barr virus].
Song T; Chen G; Zhang X; Xu Y; Chen J; Wang Y; Ye L; Xu J; Wu D; Miao J
Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(40):3135-9. PubMed ID: 25573307
[TBL] [Abstract][Full Text] [Related]
40. Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients.
Patel C; Pasciolla M; Abramova R; Salerno D; Gomez-Arteaga A; Shore TB; Orfali N; Mayer S; Hsu J; Phillips AA; Chaekal OK; Satlin MJ; Soave R; Kodiyanplakkal RPL; Drelick A; Plate M; Besien KV
Transplant Cell Ther; 2023 Feb; 29(2):132.e1-132.e5. PubMed ID: 36334653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
